AURO-RISEDRONATE

auro pharma inc🇨🇦 Health Canada

Approval Id: ddf60ae40a2f4a69
Drug Approval Canada Name: AURO-RISEDRONATE
Product Name: AURO-RISEDRONATE
Status: Dormant
Status Date: 2020-07-24
Original Market Date: 2016-04-13
Din: 02442760
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:24.00
Atc Original: M05BA07 RISEDRONIC ACID
Atc Name: m 05 ba 07
Aig Number: 0135301005
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ddf60ae40a2f4a69

Type

Standard